ArticleCureus2025
Severe Hyponatremia From Lupus-Related Syndrome of Inappropriate Antidiuresis (SIADH): A Diagnostic Challenge.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Severe hypotonic hyponatremia can complicate systemic lupus erythematosus (SLE) via inflammation-driven non-osmotic vasopressin release, leading to the syndrome of inappropriate antidiuresis (SIADH). We report a 24-year-old woman with active SLE who presented with headache, emesis, and confusion. She was clinically euvolemic, with a serum sodium level of 112 mmol/L, a measured serum osmolality of 254 mOsm/kg, a urine osmolality of 620 mOsm/kg, and a urine sodium level of 64 mmol/L; thyroid and adrenal tests were normal. Neuroimaging was unremarkable. Given severe symptoms, we administered guideline-based 3% hypertonic saline boluses while implementing a proactive desmopressin (DDAVP) clamp to prevent aquaresis-driven overcorrection; targets were an initial rise of 4-6 mmol/L and ≤8-10 mmol/L per 24 hours. Fractional excretion of urate (FEurate) decreased to 5% after partial correction, supporting SIADH over cerebral/renal salt wasting. Sodium was corrected safely with frequent monitoring and a standing re-lowering protocol available if limits were exceeded. This case underscores lupus-related SIADH as an important cause of profound hyponatremia and highlights a practical algorithm - hypertonic saline plus DDAVP clamp, FEurate reassessment, and conservative correction goals - to achieve safety while definitive lupus therapy proceeds.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.